Graded rehab and self-made programmes
What studies of graded rehab and self-made programmes found
At a glance, by condition
Both together: C Might help, very uncertain
Based on the strongest evidence, studies with no comparison group (very low certainty), for overall symptoms.
1 outcome rated · see each below
How we got this
Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.
What this means: Graded rehab and self-made programmes might help some people with long COVID and ME/CFS studied together, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.
Ask about this treatment
The grades, in plain words
Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.
- AHelpsImprovement, high certaintyProbably helpsImprovement, moderate certainty
- BMay helpImprovement, low certainty
- Graded rehab and self-made programmes · Both together is hereCMight help, very uncertainImprovement, very low certaintyMixed resultsStudies disagree
- DLittle or no differenceStudies found little or no difference
- FHarmsIt made things worse
By symptom and daily life
Both together
Daily life and health overall
Overall symptoms1 study · 1 (few people) person took part in graded rehab and self-made programmes Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · several months (few people)
Overall symptoms improved.
The evidence is very uncertain about the effect of graded rehab and self-made programmes on overall symptoms in ME/CFS or long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
Fibromyalgia and Chronic Fatigue Syndrome (2009)
- People in the study
- 1 in the study
- Dose
- —
- Outcome
- full recovery
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Studies of combinations
Outcomes that only studies of graded rehab and self-made programmes given together with other treatments looked at. Shown, not graded: they can’t tell what graded rehab and self-made programmes did alone.
Daily functioning Long COVID
Combination: Graded rehab and self-made programmes1 in the study
Long COVID-Challenges in diagnosis and managing return-to-work. (2023): functional limitations, better (not tested).
Shown, not counted: graded rehab and self-made programmes was given together with other treatments.
Fatigue Long COVID
Combination: Graded rehab and self-made programmes1 in the study
Long COVID-Challenges in diagnosis and managing return-to-work. (2023): feeling fatigued in his daily functioning, better (not tested).
Shown, not counted: graded rehab and self-made programmes was given together with other treatments.
Cognition (brain fog) Long COVID
Combination: Graded rehab and self-made programmes1 in the study
Long COVID-Challenges in diagnosis and managing return-to-work. (2023): difficulties in concentration at work, better (not tested).
Shown, not counted: graded rehab and self-made programmes was given together with other treatments.
Side effects
No study of this treatment alone reported side effects we could read.
All papers
- Corona With Lyme: A Long COVID Case Study.2023 · case report · 1 in the study
Summary
This case report describes a previously healthy 26-year-old female medical student living in New York, NY, who developed long COVID after a presumed acute SARS-CoV-2 infection in March 2020, with a concurrent perceived early-disseminated Lyme disease infection. The three-year arc covers numerous trial-and-error treatments: a two-week regimen of doxycycline 100 mg twice a day, metformin escalation alongside diet modifications, graded compression stockings, breathing exercises, increases in caffeine and salt consumption with increased fluid intake, a horizontal cardio exercise program with rest periods, osteopathic manipulative treatment, cognitive behavioral therapy, sleep hygiene improvements, supplements (vitamin C, vitamin D, vitamin B12, B-complex, n-acetyl cysteine, turmeric extract), a two-dose Moderna mRNA COVID-19 vaccination course, and abortive headache therapies (Excedrin or Fioricet and prochlorperazine). The authors report a moderate reduction in cycle length and morning hypoglycemic symptoms with metformin, a moderate reduction in myalgias, headaches and scalp allodynia with osteopathic manipulative treatment, some relief of post-COVID headache, help with headache pain, orthostatic palpitations, fatigue and brain fog from abortive therapies plus caffeine, salt and fluid intake, moderate improvements in fatigue and brain fog in the first 24 hours after the first vaccine dose, moderate symptom alleviation from digital interventions, and small but recognizable differences in fatigue and cognition from sleep hygiene. No improvement in symptoms other than mild reduction in right shoulder pain followed the doxycycline regimen. Supplements provided no discernable benefit. The patient reports full recovery from long COVID with residual blurred vision and oligomenorrhea. Reported harms include worsening blurred vision, palpitations, heat intolerance and near-syncopal events; a moderate increase in fatigue and brain fog with a CGRP antagonist; fatigue exacerbation with traditional exercise rehabilitation; symptom re-exacerbations with compression stockings; and increased headache frequency and duration with n-acetyl cysteine. The abstract describes near-total remission.
- Fibromyalgia and Chronic Fatigue Syndrome2009 · case report · 1 in the study
Summary
The abstract describes one patient, Sue Ellen, with fatigue and weakness; the title names fibromyalgia and chronic fatigue syndrome. The report has no comparison group and is not described as randomised or as a crossover study. With help from family and friends, a program of steadily increasing activities and school attendance was devised. The duration and follow-up are reported as several months. The abstract states that she made steady progress to a full recovery and that it took several months for her to resume her normal activities. It also states that she had been treated for Lyme disease—despite negative blood tests—with no response. Harms, withdrawals, blinding, allocation concealment, funding, conflicts, and setting are not reported. The authors state no formal conclusion or limitations in the abstract. Limits evident from the report are the single-patient account and the absence of a comparison group, randomisation, or a stated study design.
- Long COVID-Challenges in diagnosis and managing return-to-work.2023 · combination: given with other treatments · 1 in the study
Summary
This case report described one 27-year-old male Occupational Health trainee working as a government public health officer in an office environment who had long COVID. He developed his own rehabilitation plan, a gradual fitness plan starting with walks over 10–20 min for 1–2 km three times a week, with vertical steps up to nine floors once he could keep pace without feeling overly tired, and he began rehabilitating himself. The duration was 2 months, with follow-up in October 2020, 2 months after the initiation of his rehabilitation. There was no comparison group. Outcomes reported were effort tolerance, feeling fatigued in daily functioning, difficulties in concentration at work, functional limitations, and return-to-work. At follow-up he reported that his effort tolerance had improved back to his pre-infection status, without feeling fatigued in his daily functioning, and there were no further difficulties in concentration at work. The abstract stated that progressive efforts to build up his physical fitness complemented with workplace adjustments helped to overcome his functional limitations and allowed him to effectively return-to-work. Harms, withdrawals, and people who worsened or stopped were not reported. The authors noted challenges in diagnosing long COVID with lack of a consensus case definition; they did not state study limitations.